REF:

C3110 (Cassette)

INTENDED USE：

Zika Virus IgM/IgG Antibody Joint Test is a lateral flow chromatographic immunoassay for the qualitative detection of IgM/IgG anti-zika virus (ZIKA) in human serum, plasma or whole blood. It is intended to be used as a screening test and as an aid in the diagnosis of infection with ZIKA. Any reactive specimen with the Zika Virus IgM/IgG Antibody Joint Test must be confirmed with alternative testing method(s) and clinical findings.

SUMMARY：

Zika Virus (Zika): mainly transmitted through the bite of Aedes mosquito, mother and child, blood transfusion and sexual transmission. Because there is no vaccine at present, people is generally susceptible to infection. IgG/IgM antibody is produced one week after onset, so the detection of IgG/IgM is of great significance for the early diagnosis of Zika virus. Zika is diagnosed based on serological analysis and viral isolation in mice or tissue culture. An IgM immunoassay is the most practical lab test method. Zika Virus IgM/IgG Antibody Joint Test utilizes recombinant antigens derived from its structure protein, it detects IgM/IgG anti-zika in patient serum or plasma within 15 minutes. The test can be performed by untrained or minimally skilled personnel, without cumbersome laboratory equipment.